<p>The UK is committed to rapid equitable access to safe and effective vaccines. We are among the largest donors to the COVAX Advance Market Commitment (AMC), committing £548 million which leveraged through match funding $1 billion from other donors in 2020. This support to COVAX has been critical to it supplying COVID-19 vaccines to over 120 countries and economies. We have also committed to share the majority of our supply of any surplus vaccine doses with COVAX. Trinidad and Tobago are a self-financing participant of COVAX and have received 67,200 AstraZeneca doses to date out of an initial order of 100,800 doses.</p>